Advertisement
Screener

GeneDx Holdings Corp. (WGS) Capital Leases, Income Statement, Interest Expense

GeneDx Holdings Corp. Capital Leases, Income Statement, Interest Expense

GeneDx Holdings Corp. (WGS) reported Capital Leases, Income Statement, Interest Expense of $600.00 thousand for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-15.

Discontinued › Expense Statement › Interest Expense

us-gaap:CapitalLeasesIncomeStatementInterestExpense · last filed 2021-11-15

  • GeneDx Holdings Corp. capital leases, income statement, interest expense for the quarter ending 2021-09-30 was $600.00K, a 0.00% change year-over-year.
  • GeneDx Holdings Corp. capital leases, income statement, interest expense for the quarter ending 2020-09-30 was $600.00K.
Period endCapital Leases, Income Statement, Interest Expense 3 monthCapital Leases, Income Statement, Interest Expense 9 month
2021-09-30$600.00K
10-Q · filed 2021-11-15
$1.70M
10-Q · filed 2021-11-15
2020-09-30$600.00K
10-Q · filed 2021-11-15
$1.70M
10-Q · filed 2021-11-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
Privia Health Group, Inc. (PRVA)United States$2.477B115.52
Pennant Group, Inc. (PNTG)United States$1.386B39.84
U S PHYSICAL THERAPY INC /NV (USPH)United States$1.251B32.48
Omada Health, Inc. (OMDA)United States$1.207B309.08
InnovAge Holding Corp. (INNV)United States$1.206B-635.60
LifeStance Health Group, Inc. (LFST)United States$4.510B80.86
Strata Critical Medical, Inc. (SRTA)United States$0.467B11.33
DocGo Inc. (DCGO)United States$0.034B-0.25
VSEE HEALTH, INC. (VSEE)United States$0.003B
Agape ATP Corp (ATPC)$0.002B